<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>FLAXSEEDÂ - flax seedÂ injection, solutionÂ </strong><br><strong>COFFEEÂ - arabica coffee beanÂ injection, solutionÂ </strong><br><strong>COTTONSEEDÂ - cotton seedÂ injection, solutionÂ </strong><br>Antigen Laboratories, Inc.<br></p></div>
<h1>Allergenic Extract â€œFor Diagnostic Use Onlyâ€?</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Warning">
<a name="inv-91af3407-0736-486c-ba4d-e7816cde1cd3"></a><a name="section-1"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><a name="inv-0245b6f8-15df-4a09-9947-e82e0f11951a"></a><span class="Bold">Allergenic extract is intended for use by physicians or under the guidance of physicians who are experienced in the administration of allergenic extracts for diagnosis and the emergency care of <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>. This extract is not directly interchangeable with other allergenic extracts. Patients should be instructed to recognize adverse reaction symptoms and cautioned to contact the physician's office if reaction symptoms occur. As with all allergenic extracts, severe systemic reactions may occur.</span><span class="Italics"><span class="Bold">In certain individuals, especially in steroid-dependent/unstable <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthmatics</span>, these life-threatening reactions may result in <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span></span><span class="Bold">.</span></span><span class="Bold">Patients should be observed for at least 20 minutes following testing. Emergency measures, as well as trained personnel, should be immediately available in the event of a life-threatening reaction.</span></p>
<p><a name="inv-08a965c6-5c41-4b46-805e-bd2ccfc4547e"></a><span class="Bold">This product should not be injected intravenously. See the "WARNINGS", "PRECAUTIONS", "ADVERSE REACTIONS" and "OVERDOSAGE" sections.</span></p>
<p><a name="inv-7e164f89-66a5-48ad-8181-dc0ea72ceffe"></a><span class="Bold">Sensitive patients may experience severe <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reactions</span> resulting in respiratory obstruction, <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span>, <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span> and/or <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>.</span></p>
<p><a name="inv-2daeb48a-8057-46dd-a79d-09102df383c3"></a><span class="Bold">Report serious adverse events to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787, phone 1-800-FDA-1088.</span></p>
<p><a name="inv-3bec21c1-53a9-457f-8942-4a67f994eebd"></a><span class="Italics"><span class="Bold">Patients receiving beta-blockers may not be responsive to epinephrine or inhaled bronchodilators</span><span class="Bold">.</span></span><span class="Bold">Respiratory obstruction not responding to parenteral or inhaled bronchodilators may require theophylline, oxygen, intubation and the use of life support systems. Parenteral fluid and/or plasma expanders may be utilized for treatment of <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span>. Adrenocorticosteroids may be administered parenterally or intravenously. Refer to ''WARNINGS", "PRECAUTIONS" and "ADVERSE REACTIONS" sections below.</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="inv-8acf902b-41f5-4370-b51b-5b35144d9ca9"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First"><a name="inv-52f3a5dc-a679-4b17-8b2b-a3e351cea368"></a>Antigen Laboratories' allergenic extracts are manufactured from source material listed on the vial label. The extract is a sterile solution containing extractables of source materials obtained from biological collecting and/or processing firms. All source materials are inspected by Antigen Laboratories' technical personnel in accordance with 21 CFR 680.1 (b) (I). </p>
<p><a name="inv-621438dc-652c-47f2-ac32-8cf0790853d8"></a>The following "For Diagnostic Use Only" allergenic extracts are extracted at a 1:20 w/v or 1:50 w/v ratio of source material to extracting fluid: </p>
<p><a name="inv-49f0abc0-c587-4efe-8431-14dc2a023f23"></a>The source material for Coffee is prepared by grinding the seed of the coffee plant (<span class="Italics">Coffea arabic</span>). </p>
<p><a name="inv-8094dffb-43d9-4df7-ad84-73387bcac5a2"></a>The source material for Cottonseed is prepared by grinding the seed of the cotton plant (<span class="Italics">Gossypium spp.</span>). </p>
<p><a name="inv-b3718cf5-e19f-4696-b051-89c72c87369b"></a>The source material for Flaxseed is prepared by grinding the seed of the flax plant (<span class="Italics">Linum usitatissimum</span>). </p>
<p><a name="inv-ee532190-899d-49e3-bfb7-5d0303f5a49e"></a>Leafhopper source material is pulverized whole bodies of Leafhoppers (Cicadellidae). </p>
<p><a name="inv-601e1f02-e799-4870-811e-8ef9837679f2"></a>Miller Moth source material is pulverized whole bodies of night flying moths (Lepidoptera). </p>
<p><a name="inv-5e10820b-9d6b-445a-b16e-c9f2c63819a7"></a>Cricket source material is pulverized whole bodies of crickets (Gryllidae). </p>
<p><a name="inv-bd0dcf46-1d7e-4cec-b8f9-ffa48be1dcfb"></a>Moth source material is pulverized whole bodies of moths of the order Frenatae. </p>
<p><a name="inv-9023774a-6a63-4472-8736-6a1d9c1c684a"></a>The routes of administration for diagnostic purposes are intradermal or prick-puncture of the skin. 	</p>
<p><a name="inv-d2f5c835-6b46-403c-b7f4-f90067d45afe"></a>FOR ALLERGENIC EXTRACTS CONTAINING 50% V/V GLYCERINE AS PRESERVATIVE AND STABILIZER: </p>
<p><a name="inv-a0e61dc7-202a-4a7c-9319-cebdaad771c1"></a><span class="Bold">INACTIVE INGREDIENTS:</span></p>
<p><a name="inv-025950c4-c8e8-4799-b196-1c314d433bb8"></a>	Sodium chlorideâ€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦...0.95%</p>
<p><a name="inv-29624fe7-4e1b-4d4f-9dc8-3da467ac9766"></a>	Sodium bicarbonateâ€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦.0.24%</p>
<p><a name="inv-81eaa8d9-860a-40de-8f85-297f824d6cc4"></a>	USP Glycerineâ€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦50% (v/v)</p>
<p><a name="inv-e242c03c-7165-4ef8-8364-cd4d6b3f3b89"></a>	Water for Injectionâ€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦â€¦q.s. to volume</p>
<p><a name="inv-cb872360-fa96-4322-906a-baa99f415505"></a>Active allergens are described by common and scientific name on the stock concentrate container label. </p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="inv-a7794156-77bd-497e-9dd9-8d48c1e85800"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First"><a name="inv-4830e426-ad44-45ae-a5ba-50b3fe1c7332"></a>Studies indicate allergic individuals produce immunoglobulins of the IgE class in response to exposure to allergens. Subsequent exposure to the same allergen results in a complex of allergen with IgE antibody fixed on mast cells or basophil membranes. This cross-linking results in stimulation of mast cells which leads to release and generation of pharmacologically active substances that produce <span class="product-label-link" type="condition" conceptid="4223759" conceptname="IgE-mediated allergic disorder">immediate hypersensitivity reaction</span>.<span class="Sup">1</span></p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="inv-36b49efd-ab25-48e6-8a6c-8b1320dec893"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First"><a name="inv-4a8e88e7-727d-43c4-9de2-369ec7c6d28e"></a>FOR DIAGNOSTIC USE ONLY. This product has not been shown by adequate data to be safe and effective for therapeutic use according to Federal Register Notice dated November 16, 1994, Vol. 59, No. 220. The following allergenic extracts are "For Diagnostic Use Only": Coffee (<span class="Italics">Coffea arabic</span>), Cottonseed (<span class="Italics">Gossypium spp.</span>), Flaxseed (<span class="Italics">Linum usitatissimum</span>), Leafhopper (Cicadellidae), Miller Moth (Night Flying Lepidoptera), Cricket (Gryllidae) and Moth (Frenatae). These extracts are intended for diagnostic testing of patients whose histories indicate that upon natural exposure to the allergen, they experience allergic symptoms. Confirmation is determined by skin testing.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="inv-ef9e4e43-eb9e-409c-80d0-afb62712e9af"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><a name="inv-cc6a5b04-9b37-4513-956a-61d4b4882662"></a>Do not administer in the presence of diseases characterized by <span class="product-label-link" type="condition" conceptid="437312" conceptname="Bleeding">bleeding</span> diathesis. Individuals with autoimmune disease may be at risk of exacerbating symptoms of the underlying condition, possibly due to routine immunization. Children with <span class="product-label-link" type="condition" conceptid="195314" conceptname="Nephrotic syndrome">nephrotic syndrome</span> should not receive injections due to immunization exacerbating nephrotic diseases. </p>
<p><a name="inv-a473ef7f-2d93-489d-b5d3-acf137f5667e"></a>Allergenic extracts are not intended for diagnosing patients who do not manifest <span class="product-label-link" type="condition" conceptid="4223759" conceptname="IgE-mediated allergic disorder">immediate hypersensitivity reactions</span> to the allergenic extract when skin tested. </p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="inv-00b3669b-0536-4754-816a-bcf6881b1691"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><a name="inv-310723ca-fd79-4fce-91a5-82c462d15ec9"></a>Extreme caution is necessary when using diagnostic skin tests in highly sensitive patients who have experienced severe symptoms or <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span> by natural exposure or previous skin testing or treatment. <span class="Italics">IN THESE CASES THE POTENCY FOR SKIN TESTS MUST BE ADJUSTED TO THE PATIENT'S SENSITIVITY AND TOLERANCE.</span> Refer to boxed â€œWARNINGS" and â€œOVERDOSAGE" sections. </p>
<p><a name="inv-223bebef-7a6b-483a-b981-98cf8b9fde4b"></a>Epinephrine 1:1000 should be available when a new lot of allergenic extract is utilized. Patient re-evaluation may be necessary. Injections should never be given intravenously. Adverse reactions to allergenic extracts are usually apparent within 20-30 minutes following skin testing. Patients should be observed for 20-30 minutes after skin testing. </p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="inv-c0c8c676-0f69-4ef7-8722-934facecfeb4"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First"><a name="inv-73d5cfa1-8159-4ef1-b3ae-9d22121750f7"></a>General: </p>
<p><a name="inv-e68a678a-2cb1-425e-874e-0940291c4506"></a>Sterile solutions, vials, syringes, etc. must be used. Aseptic technique should be observed in making dilutions for skin testing. </p>
<p><a name="inv-de681c6a-b77c-422b-a3be-9472fca931a8"></a><span class="Bold">DO NOT INJECT INTRAVENOUSLY</span></p>
<p><a name="inv-62b5d8a8-1cfb-4efc-a2c8-f2d3bc21f807"></a>Observe caution in making test injection to minimize adverse reactions. The usual precautions in administering allergenic extracts are necessary (refer to boxed "WARNINGS" and "OVERDOSAGE" sections). A disposable, sterile syringe and needle should be used for each individual patient to prevent transmission of <span class="Italics"><span class="product-label-link" type="condition" conceptid="4281232" conceptname="Type B viral hepatitis">serum hepatitis</span>, Human <span class="product-label-link" type="condition" conceptid="433740" conceptname="Immunodeficiency disorder">Immunodeficiency</span> Virus (HIV)</span> and other infectious agents. </p>
<p><a name="inv-5bf45f78-2761-4cf0-9a42-f507f71cc441"></a>It cannot be overemphasized that, under certain unpredictable combinations of circumstances, <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic shock</span> is always a possibility. Other possible systemic reaction symptoms are, in varying degrees of severity: <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">fainting</span>, <span class="product-label-link" type="condition" conceptid="4260836" conceptname="Blanching of skin">pallor</span>, <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span>, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioedema</span>, <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span>, <span class="product-label-link" type="condition" conceptid="314754" conceptname="Wheezing">wheezing</span>, <span class="product-label-link" type="condition" conceptid="379019" conceptname="Conjunctivitis">conjunctivitis</span>, <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">rhinitis</span>, and <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>.<span class="Sup">4,5</span></p>
<p><a name="inv-af3562db-4fc1-4aec-ba44-79cf3397d8f6"></a>With careful attention to administration, such reactions occur infrequently, but it must be remembered that allergenic extracts are highly potent to sensitive individuals and <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> could result in anaphylactic symptoms. Therefore, it is imperative that physicians administering allergenic extracts understand and be prepared for the treatment of severe reactions. </p>
<p><a name="inv-1b24a2f4-e93a-48dd-b6e7-62176bcddd4d"></a>Refer to "OVERDOSAGE" section for a description of the treatment of <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reactions</span>. </p>
<p><a name="inv-7f7383b4-f346-4759-91bf-65336a13c649"></a>Information for Patients: </p>
<p><a name="inv-36dcdce8-5fba-4e0c-bfd7-4dc7672304b9"></a>Patients should remain under observation of nurse, physician, or other personnel trained in emergency measures for at least 20 minutes following testing. Any adverse reactions during or after leaving the office should be reported to the physician or their qualified personnel. </p>
<p><a name="inv-336818a5-557c-41d0-865d-d33e9e701a7c"></a>Carcinogenesis, Mutagenesis, Impairment of Fertility: </p>
<p><a name="inv-eb627c11-d62e-48b7-8eb6-4fe98b459a22"></a>Long term studies in animals have not been conducted with allergenic extract to determine their potential for carcinogenicity, mutagenicity or impairment of fertility. </p>
<p><a name="inv-9c44727e-9245-46a4-a6c8-0f0581ba09d6"></a>Pregnancy Category C: </p>
<p><a name="inv-97791996-65e0-4160-af83-67f1a33054b4"></a>Animal reproduction studies have not been conducted with allergenic extracts. It is not known whether allergenic extracts cause fetal harm during pregnancy or affect reproductive capacity. A systemic reaction to allergenic extract could cause uterine contractions leading to <span class="product-label-link" type="condition" conceptid="4067106" conceptname="Miscarriage">spontaneous abortion</span> or <span class="product-label-link" type="condition" conceptid="4273560" conceptname="Premature labor">premature labor</span>. Allergenic extracts should be used during pregnancy only if potential benefit justifies potential risk to fetus.<span class="Sup">3</span></p>
<p><a name="inv-465a3d64-6caa-4188-842a-31301445671c"></a>Nursing Mothers: </p>
<p><a name="inv-dfc61c38-1547-4af3-95f9-29648f068e95"></a>It is not known whether allergenic extracts are excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when allergenic extracts are administered to a nursing woman. </p>
<p><a name="inv-610c22a9-cc66-44d4-a961-300626b931d4"></a>Pediatric Use: </p>
<p><a name="inv-49338101-6c7b-4610-a30b-7523c47531a9"></a>Allergenic extracts have been used routinely in children, and no special safety problems or specific hazards have been found.<span class="Sup">7,8</span></p>
<p><a name="inv-d5a77c44-a35e-4d38-9c37-86751590fb53"></a>Drug Interactions: </p>
<p><a name="inv-ec39d26c-5bf1-4b5e-9282-99712bb9a117"></a><span class="Bold">Antihistamines.</span> Antihistamines inhibit the wheal and flare reaction. The inhibitory effect of conventional antihistamines varies from 1 day up to 10 days, according to the drug and patient's sensitivity. Long acting antihistamines (e.g., astemizole) may inhibit the wheal and flare for up to forty days. </p>
<p><a name="inv-10933cdc-5a8b-4494-9d2d-926a1cdc1210"></a><span class="Bold">Imipramines, phenothiazines, and tranquilizers.</span> Tricyclic antidepressants exert a potent and sustained decrease of <span class="product-label-link" type="condition" conceptid="4089139" conceptname="Skin reaction">skin reactions</span> to histamine that may last for a few weeks. Tranquilizers and antiemetic agents of the phenothiazine class have H<span class="Sub">1</span> antihistaminic activity and can block skin tests.<span class="Sup">2</span></p>
<p><a name="inv-64e7f816-0610-41d7-b065-7769a3ecca52"></a><span class="Bold">Corticosteroids.</span> Short-term (less than 1 week) administration of corticosteroids at the therapeutic doses used in <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthmatic</span> patients does not modify the cutaneous reactivity to histamine, compound 48/80, or allergen. Long-term corticosteroid therapy modifies the skin texture and makes the interpretation of immediate skin tests more difftcult.<span class="Sup">2</span></p>
<p><a name="inv-d303a5de-76ab-48fd-b87f-b21d24b7a913"></a><span class="Bold">Theophylline.</span> It appears that theophylline need not be stopped prior to skin testing. <span class="Sup">2</span></p>
<p><a name="inv-ad41569d-f1d7-4b8b-ae32-52f83acba066"></a><span class="Bold">Beta-adrenergic agents.</span> Inhaled beta<span class="Sub">2</span> agonists in the routine doses for the treatment of <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span> do not usually inhibit allergen-induced skin tests. However, oral terbutaline and parenteral ephedrine were shown to decrease the allergen-induced wheal.<span class="Sup">2</span></p>
<p><a name="inv-5edef4eb-bd8b-46e1-a512-7493d7a36caf"></a><span class="Bold">Cromolyn.</span> Cromolyn inhaled or injected prior to skin tests with allergens or degranulating agents does not alter the skin whealing response.<span class="Sup">2</span></p>
<p><a name="inv-63b01d15-bdea-49be-aa76-b5c81f31de31"></a><span class="Bold">Other drugs.</span> Other drugs have been shown to decrease skin test reactivity. Among them, dopamine is the best-documented compound.<span class="Sup">2</span></p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="inv-35278552-9b22-4ec5-82ac-2d51918e9a85"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><a name="inv-d6d70b02-6e21-4b77-94aa-ff34a417a5a4"></a>Adverse reactions include, but are not necessarily limited to <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span> of the extremities, respiratory <span class="product-label-link" type="condition" conceptid="314754" conceptname="Wheezing">wheezing</span> or <span class="product-label-link" type="condition" conceptid="317009" conceptname="Asthma">asthma</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>, <span class="product-label-link" type="condition" conceptid="438555" conceptname="Cyanosis">cyanosis</span>, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="435553" conceptname="Epiphora">lacrimation</span>, marked perspiration, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span> of  the face, neck or upper chest, mild persistent clearing of the throat, hacking <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span> or persistent <span class="product-label-link" type="condition" conceptid="4328356" conceptname="Sneezing">sneezing</span>. </p>
<p><a name="inv-9e3b3562-71c4-45c4-8dcb-88c66cddf96f"></a>1) Local Reactions </p>
<p><a name="inv-78648c4f-c28e-415b-ba25-1a285413f907"></a>	A small amount of <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> and <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span> at the site of injection is common, the extent varying with the patient. Such reactions should not be considered significant unless they persist for at least 24 hours or exceed 50 mm in diameter. </p>
<p><a name="inv-7517ef2c-bb51-42cc-9d32-ba631ce5e984"></a>	Large, persistent local reactions or minor exacerbations of the patient's allergic symptoms may be treated by local <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">cold</span> applications and/or the use of oral antihistamines, but they should be considered a warning of possible severe systemic reactions. </p>
<p><a name="inv-844d7059-f653-4082-9ff4-fc3beff503d2"></a>	A mild burning immediately after the injection is to be expected; this usually is relieved in 10-20 seconds. </p>
<p><a name="inv-1eb641f6-b5cd-4f63-9954-0840cccb054e"></a>2) Systemic Reactions </p>
<p><a name="inv-7217ee12-5fd2-47bc-9c44-d4ac6c186118"></a>	Systemic reactions may range from mild exaggeration of the patient's allergic symptoms to <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reactions</span>. Very sensitive patients may show a rapid response. In some instances, a severe systemic reaction with blood pressure <span class="product-label-link" type="condition" conceptid="436583" conceptname="Fall">fall</span> and/or <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span> may occur. Quantitation of patient's sensitivity combined with careful early observation is essential for safe skin testing.<span class="Sup">9</span></p>
<p><a name="inv-d2a1d36f-327f-4401-a330-3b8c411cdfb3"></a><span class="Bold">Patients receiving beta-blockers may not be responsive to epinephrine or inhaled bronchodilators.</span> The following are commonly prescribed <span class="Bold">beta-blockers</span>: Levatol, Lopressor, Propanolol Intersol, Propanolol HCL, Blocadren, Propanolol, Inderal-LA, Visken, Corgard, Ipran, Tenormin, Timoptic. Ophthalmic beta-blockers: Betaxolol, Levobunolol, Timolol, Timoptic. Chemicals that are beta-blockers and may be components of other drugs: Acebutolol, Atenolol, Esmolol, Metoprolol, Nadolol, Penbutolol, Pindolol, Propanolol, Timolol, Labetalol, Carteolol.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="inv-1924e417-385b-4402-b0b7-928a09357fad"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First"><a name="inv-b6b96650-adb8-4505-800a-20b588d79323"></a>Refer to â€œWARNINGS," "PRECAUTIONS" and "ADVERSE REACTIONS" sections for signs and symptoms of an <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>. </p>
<p><a name="inv-d34f4eb6-6359-4259-9fed-7e899b9c9145"></a>If a systemic or <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylactic reaction</span> does occur, the first treatment should be injection intramuscularly or subcutaneously 0.3 to 0.5 ml of 1:1000 epinephrine-hydrochloride into the opposite arm or gluteal area. Apply tourniquet above site of allergenic extract injection and loosen briefly at 5 minute intervals to prevent circulatory impairment. If oxygen is indicated, it may be administered by nasal cannula or ambu bag. 	 </p>
<p><a name="inv-b2ef8e9a-f549-430b-a4a4-70d12e42fc27"></a>The epinephrine HCL 1:1000 dose for infants to 2 years is 0.05 to 0.1 ml; for children 2 to 6 years it is 0.15 ml; for children 6 to 12 years it is 0.2 ml. </p>
<p><a name="inv-a54636a0-4e16-4022-8f99-a762659c66f0"></a>Symptoms of progressive <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span> include airway obstruction and/or <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">vascular collapse</span>. </p>
<p><a name="inv-01c4ef40-426c-47a7-b5e9-99d82bc7698c"></a>After administration of epinephrine, profound <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span> and <span class="product-label-link" type="condition" conceptid="443240" conceptname="Collapse">vasomotor collapse</span> should be treated with intravenous fluids and possibly vasoactive drugs. Monitor airways for obstruction. Oxygen should be given by mask if indicated. </p>
<p><a name="inv-d0f23f5c-995a-4ecd-b360-1db00c4ab0d5"></a>Antihistamines, H<span class="Sub">2</span> antagonist, bronchodilators, steroids and theophylline may be used as indicated after giving adequate epinephrine and circulatory support.<span class="Sup">6</span></p>
<p><a name="inv-7cff1102-e3ed-4dbc-9244-5696aca71138"></a>Patients who have been taking a beta-blocker may be unresponsive to epinephrine. Epinephrine or beta-adrenergic drugs (Alupent) may be ineffective. These drugs should be administered even though a beta-blocker may have been taken. The following treatment will be effective whether or not patient is taking a beta-blocker: Aminophylline IV, slow push or drip, Atrovent (Ipratropium bromide) Inhaler, 3 inhalations repeated, Atropine, 0.4 mg/ml, 0.75 to 1.5 ml IM or IV, Solu-Cortef, 100-200 mg IM or IV, Solu-Medrol, 125 mg IM or IV, Glucagon, 0.5-1 mg IM or IV, Benadryl, 50 mg IM or IV, Cimetidine, 300 mg IM or IV, Oxygen via ambu bag.  </p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="inv-ef9c5bdf-39f1-4b20-a4f3-1716b3dbd94a"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First"><a name="inv-0f909325-84a7-4695-96a8-e3a64a96ed63"></a>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Some allergenic extracts naturally precipitate. This allergenic extract is "For Diagnostic Use Only". (Refer to STORAGE section.) </p>
<p><a name="inv-aa4133c9-c7bc-4267-a255-a248e244923a"></a><span class="Italics">PRICK-PUNCTURE TESTING:</span> To identify highly sensitive individuals and as a safety precaution, it is recommended that a prick-puncture test using a drop of the extract concentrate be performed prior to initiating very dilute intradermal testing. Prick-puncture testing is performed by placing a drop of extract concentrate on the skin and puncturing the skin through the drop with a small needle such as a bifurcated vaccinating needle. The most satisfactory sites on the back for skin testing are from the posterior axillary fold to 2.5 cm from the spinal column, and from the top of the scapula to the lower rib margins. The best areas on the arms are the volar surfaces from the axilla to 2.5 or 5 cm above the wrist, skipping the anticubital space. Skin testing should include a positive control of histamine phosphate and a negative control of 50% v/v glycerine in buffered saline. A positive reaction is approximately 10-15 mm <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> with 2.5 mm wheal. Smaller, less conclusive reactions may be considered positive in conjunction with a definitive history of symptoms on exposure to the allergen. Less sensitive individuals can be tested intradermally with an appropriately diluted extract (See "INTRADERMAL TESTING"). </p>
<p><a name="inv-9c1e549d-904b-4801-9236-0de6ab0fe866"></a><span class="Italics">INTRADERMAL TESTING:</span> The surface of the upper and lower arm is the usual location for skin testing. A sterile, disposable syringe and needle is used for each extract tested. Intracutaneous test dilutions, five-fold or ten-fold, may be prepared from stock concentrate using physiologic saline as a diluent. (1) Start testing with the most dilute allergenic extract concentration. (2) A volume of 0.02-0.05 ml should be injected slowly into the superficial skin layers making a small bleb (superficial wheal). (3) For patients without a history of extreme sensitivity, or a negative or weakly reactive prick-puncture test, the initial dilution for skin testing should be at least 1:12,500 w/v. This initial dilution can be prepared by diluting 1:20 to 1:50 w/v (2%-5%) extracts five-fold to 5<span class="Sup">-4</span> or 1:10 w/v (10%) extracts to 5<span class="Sup">-5</span>. Dilute 1:10 w/v (10%) extracts to 10<span class="Sup">-3</span> if using ten-fold dilutions. (4) Sensitive patients with a positive prick-puncture test require a further dilution to at least 1:312,500 w/v. This dilution can be prepared by diluting 1:20 to 1:50 w/v (2%-5%) extracts to 5<span class="Sup">-6</span> or 1:10 w/v (10%) extracts to 5<span class="Sup">-7</span> (five-fold dilutions). Ten-fold dilution to 10<span class="Sup">-6</span> of a 1:10 w/v (10%) extract would be a safe starting dilution. For interpretation of <span class="product-label-link" type="condition" conceptid="4089139" conceptname="Skin reaction">skin reactions</span>, refer to chart below. If after 20 minutes no <span class="product-label-link" type="condition" conceptid="4089139" conceptname="Skin reaction">skin reaction</span> is observed, continue testing using increasing increments of the concentration until a reaction of 5-10 mm wheal and 11-30 mm <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> is obtained, or a concentration of 5<span class="Sup">-2</span> or 10<span class="Sup">-1</span> has been tested. A negative control, 50% glycerine diluted with diluent to 5<span class="Sup">-2</span> (1:25) or 10<span class="Sup">-1</span> (1:10) dilution and a positive control of histamine phosphate, should be tested and included in interpretation of <span class="product-label-link" type="condition" conceptid="4089139" conceptname="Skin reaction">skin reactions</span>.<span class="Sup">2,4</span></p>
<a name="inv-47af2a41-c52d-4118-afc7-c27e3581bf52"></a><table border="1" frame="border">
<col width="208px">
<col width="208px">
<col width="208px">
<thead valign="bottom"><tr class="Last" valign="bottom">
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom"><span class="Bold">GRADE</span></td>
<td class="Botrule Rrule Toprule" align="center" valign="bottom"><span class="Bold">mm <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">ERYTHEMA</span></span></td>
<td class="Botrule Rrule Toprule" align="center" valign="bottom"><span class="Bold">mm WHEAL</span></td>
</tr></thead>
<tbody>
<tr class="First">
<td class="Botrule Lrule Rrule">0</td>
<td class="Botrule Rrule">less than 5</td>
<td class="Botrule Rrule">less than 5</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">Â±</td>
<td class="Botrule Rrule">5-10</td>
<td class="Botrule Rrule">5-10</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">1+</td>
<td class="Botrule Rrule">11-20</td>
<td class="Botrule Rrule">5-10</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">2+</td>
<td class="Botrule Rrule">21-30</td>
<td class="Botrule Rrule">5-10</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">3+</td>
<td class="Botrule Rrule">31-40</td>
<td class="Botrule Rrule">10-15 or with pseudopods</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule">4+</td>
<td class="Botrule Rrule">greater than 40</td>
<td class="Botrule Rrule">greater than 15 or with many pseudopods</td>
</tr>
</tbody>
</table>
<p><a name="inv-750967e8-9cd4-4dda-9a1c-30c8fadb4b55"></a><span class="Italics">INTRADERMAL TESTINGâ€“SKIN ENDPOINT TITRATION:</span> The allergenic extracts to which the patient is sensitive and the patient's degree of sensitivity can be determined through the use of intracutaneous skin tests involving progressive five-fold dilutions of allergenic extracts. Intracutaneously inject 0.01 to 0.02 ml of the test allergen to form a 4 mm diameter superficial skin wheal. For patients demonstrating a negative or weakly reactive prick-puncture skin test, an initial screening dilution of 1:12,500 w/v is safe. For patients demonstrating a positive prick-puncture skin test, an initial screening dilution of 1:312,500 w/v is safe (see "Serial Dilution Titration Test Dilutions" chart below).When a sequence of five-fold or ten-fold dilutions of an allergen is injected, the endpoint is determined by noting the dilution that first produces a wheal or <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> (15 minutes after injection) that is 2 mm larger than <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">wheals</span> with <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> produced by weaker, non-reacting dilutions (5 mm negative wheal). </p>
<a name="inv-ea2b1684-b632-4156-90c4-5eab7a3fe139"></a><table border="1" frame="border">
<caption><span>SERIAL DILUTION TITRATION TEST DILUTIONS APPROXIMATE ALLERGENIC EXTRACT CONCENTRATION RESULTING FROM 1:5 DILUTION</span></caption>
<col width="60px">
<col width="68px">
<col width="92px">
<col width="108px">
<col width="100px">
<col width="100px">
<col width="100px">
<col width="100px">
<thead valign="bottom">
<tr valign="bottom">
<td class="Botrule Lrule Rrule Toprule" align="center" rowspan="2" valign="bottom">Titration<span class="Bold"> Number</span>
</td>
<td class="Botrule Rrule Toprule" align="center" rowspan="2" valign="bottom"><span class="Bold">Dilution Exponent</span></td>
<td class="Botrule Rrule Toprule" align="center" rowspan="2" valign="bottom"><span class="Bold">Weight / Volume</span></td>
<td class="Botrule Rrule Toprule" align="center" colspan="5" valign="bottom"><span class="Bold">Allergenic Extract Concentrate</span></td>
</tr>
<tr class="Last" valign="bottom">
<td class="Botrule Lrule Rrule Toprule" align="center" valign="bottom">
<span class="Bold">1:50</span>
   
   (<span class="Bold">2%)</span>
</td>
<td class="Botrule Rrule Toprule" align="center" valign="bottom">
<span class="Bold">1:40</span>
   
   (<span class="Bold">2 1/2%)</span>
</td>
<td class="Botrule Rrule Toprule" align="center" valign="bottom">
<span class="Bold">1:33 1/3</span>
   
   (<span class="Bold">3%)</span>
</td>
<td class="Botrule Rrule Toprule" align="center" valign="bottom">
<span class="Bold">1:20</span>
   
   (<span class="Bold">5%)</span>
</td>
<td class="Botrule Rrule Toprule" align="center" valign="bottom">
<span class="Bold">1:10</span>
   
   (<span class="Bold">10%)</span>
</td>
</tr>
</thead>
<tbody>
<tr class="First">
<td class="Botrule Lrule Rrule">No. 1</td>
<td class="Botrule Rrule">5<span class="Sup">-1</span>
</td>
<td class="Botrule Rrule">1:5</td>
<td class="Botrule Rrule">1:250</td>
<td class="Botrule Rrule">1:200</td>
<td class="Botrule Rrule">1:167</td>
<td class="Botrule Rrule">1:100</td>
<td class="Botrule Rrule">1:50</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">No. 2</td>
<td class="Botrule Rrule">5<span class="Sup">-2</span>
</td>
<td class="Botrule Rrule">1:25</td>
<td class="Botrule Rrule">1:1,250</td>
<td class="Botrule Rrule">1:1,000</td>
<td class="Botrule Rrule">1:835</td>
<td class="Botrule Rrule">1:500</td>
<td class="Botrule Rrule">1:250</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">No. 3</td>
<td class="Botrule Rrule">5<span class="Sup">-3</span>
</td>
<td class="Botrule Rrule">1:125</td>
<td class="Botrule Rrule">1:6,250</td>
<td class="Botrule Rrule">1:5,000</td>
<td class="Botrule Rrule">1:4,175</td>
<td class="Botrule Rrule">1:2,500</td>
<td class="Botrule Rrule">1:1,250</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">No. 4</td>
<td class="Botrule Rrule">5<span class="Sup">-4</span>
</td>
<td class="Botrule Rrule">1:625</td>
<td class="Botrule Rrule">1:31,250</td>
<td class="Botrule Rrule">1:25,000</td>
<td class="Botrule Rrule">1:20,875</td>
<td class="Botrule Rrule">1:12,500</td>
<td class="Botrule Rrule">1:6,250</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">No. 5</td>
<td class="Botrule Rrule">5<span class="Sup">-5</span>
</td>
<td class="Botrule Rrule">1:3,125</td>
<td class="Botrule Rrule">1:156,250</td>
<td class="Botrule Rrule">1:125,000</td>
<td class="Botrule Rrule">1:104,375</td>
<td class="Botrule Rrule">1:62,500</td>
<td class="Botrule Rrule">1:31,250</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">No. 6</td>
<td class="Botrule Rrule">5<span class="Sup">-6</span>
</td>
<td class="Botrule Rrule">1:15,625</td>
<td class="Botrule Rrule">1:781,250</td>
<td class="Botrule Rrule">1:625,000</td>
<td class="Botrule Rrule">1:521,875</td>
<td class="Botrule Rrule">1:312,500</td>
<td class="Botrule Rrule">1:156,250</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">No. 7</td>
<td class="Botrule Rrule">5<span class="Sup">-7</span>
</td>
<td class="Botrule Rrule">1:78,125</td>
<td class="Botrule Rrule">1:3,906,250</td>
<td class="Botrule Rrule">1:3,125,000</td>
<td class="Botrule Rrule">1:2,609,375</td>
<td class="Botrule Rrule">1:1,562,500</td>
<td class="Botrule Rrule">1:781,250</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">No. 8</td>
<td class="Botrule Rrule">5<span class="Sup">-8</span>
</td>
<td class="Botrule Rrule">1:390,625</td>
<td class="Botrule Rrule">1:19,531,250</td>
<td class="Botrule Rrule">1:15,625,000</td>
<td class="Botrule Rrule">1:13,046,875</td>
<td class="Botrule Rrule">1:7,812,500</td>
<td class="Botrule Rrule">1:3,906,250</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">No. 9</td>
<td class="Botrule Rrule">5<span class="Sup">-9</span>
</td>
<td class="Botrule Rrule">1:1,953,125</td>
<td class="Botrule Rrule">1:97,656,250</td>
<td class="Botrule Rrule">1:78,125,000</td>
<td class="Botrule Rrule">1:65,234,375</td>
<td class="Botrule Rrule">1:39,062,500</td>
<td class="Botrule Rrule">1:19,531,250</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">No. 10</td>
<td class="Botrule Rrule">5<span class="Sup">-10</span>
</td>
<td class="Botrule Rrule">1:9,765,625</td>
<td class="Botrule Rrule">1:488,281,250</td>
<td class="Botrule Rrule">1:390,625,000</td>
<td class="Botrule Rrule">1:326,171,875</td>
<td class="Botrule Rrule">1:195,312,500</td>
<td class="Botrule Rrule">1:97,656,250</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule">No. 11</td>
<td class="Botrule Rrule">5<span class="Sup">-11</span>
</td>
<td class="Botrule Rrule">1:48,828,125</td>
<td class="Botrule Rrule">1:2,441,406,250</td>
<td class="Botrule Rrule">1:1,953,125,000</td>
<td class="Botrule Rrule">1:1,630,859,375</td>
<td class="Botrule Rrule">1:976,562,500</td>
<td class="Botrule Rrule">1:488,281,250</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule">No. 12</td>
<td class="Botrule Rrule">5<span class="Sup">-12</span>
</td>
<td class="Botrule Rrule">1:244,140,625</td>
<td class="Botrule Rrule">1:12,207,031,250</td>
<td class="Botrule Rrule">1:9,765,625,000</td>
<td class="Botrule Rrule">1:8,154,296,875</td>
<td class="Botrule Rrule">1:4,882,812,500</td>
<td class="Botrule Rrule">1:2,441,406,250</td>
</tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="inv-0d4542dc-dfde-4cfe-86ba-8f4e963453fe"></a><a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First"><a name="inv-4acb6ae1-331a-4e95-a344-3545df07fc25"></a>	The stock concentrate of allergenic extract is expressed in weight/volume, at 1:50 w/v (2%) or 1:20 w/v (5%). It is supplied in 10, 30 and 50 ml containers. Extracts in 5 ml sterile dropper bottles are available for prick-puncture testing. To insure maximum potency for the entire dating period, all stock concentrates contain 50% glycerine v/v.</p>
</div>
<div class="Section" data-sectionCode="44425-7">
<a name="inv-23c29925-1d39-44f6-86ff-9fde4cde5f91"></a><a name="section-11"></a><p></p>
<h1>STORAGE</h1>
<p class="First"><a name="inv-888acac3-ba7d-41a4-be3b-377125546581"></a>	Store all stock concentrates and dilutions at 2-8 degrees C and keep at this temperature during office use. The expiration date of the allergenic extract is listed on the container label. Dilutions of the allergenic extract concentration containing less then 50% glycerine are less stable. If loss of potency is suspected, potency can be checked using side by side skin testing with freshly prepared dilutions of equal concentration on individuals with known sensitivity to the allergen.</p>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="inv-6eab92ab-89c7-4ef7-9447-c02e9d2e4a5b"></a><a name="section-12"></a><p></p>
<h1>REFERENCES</h1>
<p class="First"><a name="inv-9e816597-759c-48ae-a16c-212d83ab99ff"></a>      1.  	Holgate, S.T., Robinson, C., Church, Mike: Mediators of <span class="product-label-link" type="condition" conceptid="4223759" conceptname="IgE-mediated allergic disorder">Immediate Hypersensitivity</span>, Third Edition, <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergy</span> Principles and Practice, C.V. Mosby Co., Vol. I and II, pp 135-163, 1988. </p>
<p><a name="inv-ca31fe43-6e69-4d9f-82c5-54a27649da50"></a>      2. 	Bousquet, Jean: "In vivo methods for study of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span>: Skin tests" Third Edition, <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergy</span> Principles and Practice, C.V. Mosby Co., Vol. I and II, pp. 419-436, 1988. </p>
<p><a name="inv-342c9c34-292e-41c8-850e-44a361e6a242"></a>      3. 	Seebohm, P.M., et al: Panel on Review of Allergenic Extracts, Final Report, Food and Drug Administration, March 13, 1981, pp. 9-48. </p>
<p><a name="inv-2525efd9-90d8-4d79-b1b4-8e6cc5628c0d"></a>      4. 	Van Metre, T., Adkinson, N., Amodio, F., Lichtenstein, L., Mardinay, M., Norman, P., Rosenberg, G., Sobotka, A., Valentine, M.: "A Comparative Study of the Effectiveness of the Rinkel Method and the Current Standard Method of Immunology for Ragweed Pollen <span class="product-label-link" type="condition" conceptid="256439" conceptname="Allergic rhinitis due to pollen">Hay Fever</span>," The Journal of Clinical <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergy</span> and Immunology, Vol. 66, No. 6, pg. 511, December 1980. </p>
<p><a name="inv-3dc2c962-602c-46c6-a1a6-568e6e8e7c9d"></a>      5. 	Wasserman, S.: The Mast Cell and the Inflammatory Response. The Mast CeIlâ€“its role in health and disease. Edited by J. Pepys &amp; A.M. Edwards, Proceedings of an International Symposium, Davos, Switzerland, Pitman Medical Publishing Co., 1979, pp. 9-20. </p>
<p><a name="inv-1927001f-a49a-4733-9742-b8a393902df0"></a>      6. 	Wasserman, S., Marquart, D.: <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">Anaphylaxis</span>, Third Edition, <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergy</span> Principles and Practice, Vol. I, Chapter 58, p. 1365, edited by Middleton et al. </p>
<p><a name="inv-c5085c82-0a36-43a8-b204-f16939d14a93"></a>      7. 	Bullock, J., Frick, O.: Mite Sensitivity in House Dust Allergic Children, Am. J. Dis. Child.,pp. 123-222,1972. </p>
<p><a name="inv-f8978a01-1267-4124-94b4-6562c2a48d16"></a>      8. 	Willoughby, J.W.: Inhalant <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergy</span> Immunotherapy with Standardized and Nonstandardized Allergenic Extracts, American Academy of Otolaryngology-Head and Neck Surgery: </p>
<p><a name="inv-bc93a262-565d-40ff-ad31-5cc3b1276838"></a>Instructional Courses, Vol. 1, Chapter 15, C.V. Mosby Co., St. Louis, Missouri, September 1988. </p>
<p><a name="inv-cda234d7-12e9-44a0-be1b-29439bf602d0"></a>      9. 	Reid, Michael J., Lockey, Richard F., Turkeltaub M.D., Paul C., Platts-Mills, Thomas: "Survey of Fatalities From Skin Testing and Immunotherapy 1985-1989," Journal of <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Allergy</span> and Clinical Immunology, Vol. 92, No.1, pp. 6-15, 1993. </p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="inv-27bdd431-ad71-441f-a05a-22cc33d03f01"></a><a name="section-13"></a><p></p>
<h1>CONTAINER LABELING</h1>
<div class="Figure">
<a name="ID0EOFAG"></a><img alt="5 mL Blue Diagnostic Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=040dacaf-4ccf-425a-9b40-586176b7631d&amp;name=5MLBlueDiagnosticLabel.jpg">
</div>
<div class="Figure">
<a name="ID0EUFAG"></a><img alt="5 mL Red Diagnostic Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=040dacaf-4ccf-425a-9b40-586176b7631d&amp;name=5MLRedDiagnosticLabel.jpg">
</div>
<div class="Figure">
<a name="ID0E1FAG"></a><img alt="10 mL Diagnostic Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=040dacaf-4ccf-425a-9b40-586176b7631d&amp;name=10MLDiagnosticLabel.jpg">
</div>
<div class="Figure">
<a name="ID0EAGAG"></a><img alt="30/50 mL Diagnostic Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=040dacaf-4ccf-425a-9b40-586176b7631d&amp;name=30-50MLDiagnosticLabel.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>FLAXSEEDÂ 		
					</strong><br><span class="contentTableReg">flaxseed injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:49288-0201</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRADERMAL, SUBCUTANEOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>FLAX SEED</strong> (FLAX SEED) </td>
<td class="formItem">FLAX SEED</td>
<td class="formItem">0.05Â g Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GLYCERIN</strong></td>
<td class="formItem">0.525Â mL Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM CHLORIDE</strong></td>
<td class="formItem">0.0095Â g Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">BICARBONATE</span></strong></td>
<td class="formItem">0.0024Â g Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:49288-0201-1</td>
<td class="formItem">2 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:49288-0201-2</td>
<td class="formItem">5 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:49288-0201-3</td>
<td class="formItem">10 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">4</th>
<td class="formItem">NDC:49288-0201-4</td>
<td class="formItem">30 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">5</th>
<td class="formItem">NDC:49288-0201-5</td>
<td class="formItem">50 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA102223</td>
<td class="formItem">03/23/1974</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>COFFEEÂ 		
					</strong><br><span class="contentTableReg">coffee injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:49288-0100</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRADERMAL, SUBCUTANEOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ARABICA COFFEE BEAN</strong> (ARABICA COFFEE BEAN) </td>
<td class="formItem">ARABICA COFFEE BEAN</td>
<td class="formItem">0.05Â g Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GLYCERIN</strong></td>
<td class="formItem">0.525Â mL Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">BICARBONATE</span></strong></td>
<td class="formItem">0.0024Â g Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM CHLORIDE</strong></td>
<td class="formItem">0.0095Â g Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:49288-0100-1</td>
<td class="formItem">2 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:49288-0100-2</td>
<td class="formItem">5 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:49288-0100-3</td>
<td class="formItem">10 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">4</th>
<td class="formItem">NDC:49288-0100-4</td>
<td class="formItem">30 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">5</th>
<td class="formItem">NDC:49288-0100-5</td>
<td class="formItem">50 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA102223</td>
<td class="formItem">03/23/1974</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>COTTONSEEDÂ 		
					</strong><br><span class="contentTableReg">cottonseed injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:49288-0116</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRADERMAL, SUBCUTANEOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>COTTON SEED</strong> (COTTON SEED) </td>
<td class="formItem">COTTON SEED</td>
<td class="formItem">0.05Â g Â inÂ 1Â mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>GLYCERIN</strong></td>
<td class="formItem">0.525Â mL Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM CHLORIDE</strong></td>
<td class="formItem">0.0095Â g Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">BICARBONATE</span></strong></td>
<td class="formItem">0.0024Â g Â inÂ 1Â mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:49288-0116-1</td>
<td class="formItem">2 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:49288-0116-2</td>
<td class="formItem">5 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:49288-0116-3</td>
<td class="formItem">10 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">4</th>
<td class="formItem">NDC:49288-0116-4</td>
<td class="formItem">30 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">5</th>
<td class="formItem">NDC:49288-0116-5</td>
<td class="formItem">50 mL in 1 VIAL, MULTI-DOSE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BLA</td>
<td class="formItem">BLA102223</td>
<td class="formItem">03/23/1974</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Antigen Laboratories, Inc.
							(030705628)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant -Â </span>Antigen Laboratories, Inc. (030705628)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Antigen Laboratories, Inc.</td>
<td class="formItem"></td>
<td class="formItem">030705628</td>
<td class="formItem">manufacture</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 11/2009<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>afc65820-1d95-4bc6-81a6-ef5ca82cbd81</div>
<div>Set id: 040dacaf-4ccf-425a-9b40-586176b7631d</div>
<div>Version: 2</div>
<div>Effective Time: 20091112</div>
</div>
</div>Â <div class="DistributorName">Antigen Laboratories, Inc.</div></p>
</body></html>
